A new class of cancer treatments recruits the cells in our blood to fight tumors, using gene-editing tools to transform a type of white blood cell called T cell from an immune cell that usually targets bacterial or fungal infections into a living cancer drug.
A Waterford based research team have found that a nutritional supplement combination of carotenoids and trout oil may slow down Alzheimer’s disease. Positive results from taking this supplemental combination were shown at all levels of Alzheimer’s disease.
The ability to assess the impact of radiation on malignant tumors during a course of radiotherapy could help improve its effectiveness for individual patients. Based on tumor response, physicians could modify the treatment regimen and the radiation field.
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) suggest that gout is associated with a 17-20% higher risk of dementia in the elderly
A new approach established at the University of Zurich sheds light on the effects of anti-cancer drugs and the defense mechanisms of cancer cells. The method makes it possible to quickly test various drugs and treatment combinations at the cellular level
New research finds that children and adolescents who spend most of their time barefoot develop motor skills differently from those who habitually wear shoes. Published in Frontiers in Pediatrics, this is the first study to assess the relevance of growing up shod vs. barefoot on jumping, balancing and sprinting motor performance during different stages of childhood and adolescence
Romosozumab improves bone mineral density (BMD) in men with osteoporosis, but safety concerns are holding up its approval in the U.S, according to the research
Clusters of inflammatory responses after intravitreal injections have unnerved some specialists, who will share their experiences and best practices at the upcoming American Society of Retina Specialists (ASRS) 2018 Annual Meeting
The risk of venous thromboembolism (VTE) after induced abortion is higher than in nonpregnant women but lower than after live birth, Canadian researchers report
A study conducted at Lund University is now published in one of the leading hematology journal, Blood Advances, and reveals a previously unknown link between the bacteria in the gut and acute lung injury after blood transfusions.
A first-in-human study presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrates the benefits and safety of a new, long-lasting type of radionuclide therapy for patients with advanced, metastatic neuroendocrine tumors (NETs)
A research team led by a UCLA bioengineer has developed a model to predict the extent to which new laboratory-designed antibodies will be able to combat specific human diseases.